[Gene expression analysis of familial hypercholesterolemia]

Area of Science:

• Genomics
• Molecular Biology
• Bioinformatics

Context:

• Familial hypercholesterolemia (FH) is a significant risk factor for cardiovascular diseases.
• Understanding the molecular mechanisms underlying FH is crucial for developing effective treatments.

Purpose:

• To identify differentially expressed genes (DEGs) in FH.
• To uncover the underlying molecular mechanisms of FH.
• To identify potential therapeutic agents for FH.

Summary:

• Gene expression profiles of FH and normal cells were compared to identify DEGs.
• Gene Ontology (GO) and pathway analysis were performed using DAVID.
• The Connectivity Map (CMap) was utilized to compare DEGs with those induced by small molecules.
• Bioinformatics analysis revealed dysregulated metabolic processes in FH cells, including cell adhesion, material transport, signal transduction, and gene expression.
• The small molecule trazodone was identified as a potential drug candidate for restoring FH-related metabolic pathways.

Impact:

• Identified potential therapeutic agents for FH through bioinformatics analysis.
• Phenotype targeting using genomic profiling offers a rational approach to drug discovery for FH.
• Provides a new guideline for FH treatment and a potential new clinical drug for patients.